Pericytes change function depending on glioblastoma vicinity: emphasis on immune regulation

Carolina Buizza1, Robert Carlsson1, Coralie Gamper1

  • 1Department of Clinical Sciences, Translational Neurology Group, Lund University, Sweden.

Molecular Oncology
|July 17, 2025
PubMed

Insights

Mural cells (MCs) near glioblastoma (GBM) tumors change, signaling immune cells. Those further away show less activity, revealing spatial differences in GBM's immune interactions.

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Immunology

Background:

  • Glioblastoma (GBM) is an aggressive brain tumor characterized by infiltrative growth.
  • Mural cells (MCs), including pericytes and smooth muscle cells, are crucial perivascular cells involved in GBM progression.
  • MCs influence vascular co-option, the immunosuppressive tumor microenvironment, and tumor growth/migration.

Purpose of the Study:

  • To investigate spatial differences in mural cell (MC) interactions with immune cells within the glioblastoma (GBM) microenvironment.
  • To analyze the transcriptional profiles of MCs in different regions relative to the tumor mass.

Main Methods:

  • Single-cell RNA sequencing was employed to analyze MC transcriptome profiles.
  • Samples were obtained from distinct regions of mouse and human GBM tumors.
  • Ligand-receptor interactions were assessed to understand cell-cell communication.

Main Results:

  • Tumor-residing MCs displayed significant phenotypic changes, including upregulated gene expression and enhanced immune-signaling activity.
  • Region-specific ligand-receptor interactions were identified between tumor MCs and immune cells.
  • Border-residing MCs showed reduced activation and lacked distinct transcriptional profiles compared to tumor-residing MCs.

Conclusions:

  • Spatially defined transcriptional heterogeneity exists in mural cells (MCs) within the glioblastoma (GBM) microenvironment.
  • MCs play a dynamic role in the GBM microenvironment, with distinct functions based on their location.
  • These findings offer potential therapeutic targets for modulating MC-immune cell interactions in GBM treatment.